ACADIA Pharmaceuticals
ACAD
#3606
Rank
S$4.63 B
Marketcap
S$27.19
Share price
1.54%
Change (1 day)
21.88%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): S$0.17 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are S$1.07 Billion. a decrease over its 2024 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 S$0.17 B-46.18%
2024 S$0.33 B-605.67%
2023 -S$65.87 Million-76.09%
2022 -S$0.28 Billion27.41%
2021 -S$0.22 Billion-40.38%
2020 -S$0.37 Billion19.88%
2019 -S$0.31 Billion-3.92%
2018 -S$0.32 Billion-15.04%
2017 -S$0.38 Billion6.33%
2016 -S$0.35 Billion64.55%
2015 -S$0.22 Billion77.47%
2014 -S$0.12 Billion143.69%
2013 -S$48.98 Million81.93%
2012 -S$26.92 Million-8.73%
2011 -S$29.5 Million-251.39%
2010 S$19.48 M-133.2%
2009 -S$58.69 Million-30.82%
2008 -S$84.83 Million6.43%
2007 -S$79.7 Million25.89%
2006 -S$63.31 Million36.99%
2005 -S$46.22 Million37.22%
2004 -S$33.68 Million19.96%
2003 -S$28.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$43.30 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.15 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$33.20 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.03 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-S$0.16 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-S$49.86 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA